Mustang Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	6.98	76.66	110.62	98.8	62.41	16.97	35.48	27.5
Short-Term Investments	0	0	0	0	0	17.6	26	0
Cash & Cash Equivalents	6.98	76.66	110.62	98.8	62.41	34.57	61.48	27.5
Cash Growth	-90.89%	-30.70%	11.96%	58.31%	80.53%	-43.76%	123.56%	-
Receivables	3.88	0.3	0.05	0.02	0.02	0	0	0
Other Current Assets	0.48	1.9	1.04	0.72	0.63	0.55	-0.12	0
Total Current Assets	11.35	78.85	111.71	99.53	63.06	35.13	61.36	27.5
Property, Plant & Equipment	4.81	12.31	12.1	9.12	9.13	6.86	1.38	0
Other Long-Term Assets	1.58	1.26	1.36	1.25	1.25	0.77	0.75	0
Total Long-Term Assets	6.4	13.57	13.46	10.37	10.38	7.63	2.13	0
Total Assets	17.74	92.42	125.17	109.9	73.45	42.75	63.49	27.5
Accounts Payable	14.85	14.5	10.47	9.24	6.26	6.36	3.66	1.13
Deferred Revenue	0.27	0.27	0.27	0	0	0	0	0
Current Debt	0.52	0.61	0.35	0.28	1.51	0	0	0
Other Current Liabilities	-0.27	-0.27	-0.27	0	0	-0.74	-0.05	2.1
Total Current Liabilities	15.37	15.11	10.82	9.52	7.77	5.62	3.61	3.22
Long-Term Debt	1.98	30.77	1.69	1.95	14.02	0	0	0
Other Long-Term Liabilities	0.27	0.27	0.27	0	0	0.74	0.05	0
Total Long-Term Liabilities	2.25	31.04	1.96	1.95	14.02	0.74	0.05	0
Total Liabilities	17.62	46.15	12.77	11.47	21.79	6.36	3.66	3.22
Total Debt	2.5	31.38	2.03	2.23	15.53	0	0	0
Debt Growth	-92.04%	1443.63%	-8.75%	-85.65%	-	-	-	-
Retained Earnings	-380.97	-329.37	-251.84	-185.47	-125.46	-79.07	-48.41	-17.12
Shareholders' Equity	0.12	46.27	112.4	98.44	51.65	36.4	59.83	24.28
Net Cash / Debt	4.49	45.27	108.59	96.58	46.88	34.57	61.48	27.5
Net Cash / Debt Growth	-90.09%	-58.31%	12.43%	105.99%	35.61%	-43.76%	123.56%	-
Net Cash Per Share	0.52	5.89	18.53	27.55	19.50	19.24	36.52	37.41
Working Capital	-4.03	63.74	100.89	90.02	55.29	29.51	57.75	24.28
Book Value Per Share	0.01	6.02	19.18	28.08	21.48	20.26	35.54	33.02

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).